Drugs / Imotun
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01756937 Comparator | Jan 2013 → Oct 2016 | osteoarthritis, knee | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Imotun | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01756937 ↗ |
| Route | Oral | “300.03mg/cap,orally, 1 capsule once daily for 24 weeks” NCT01756937 ↗ |